| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/14/2005 | CA2776997A1 Method for the production of a cell and/or tissue and/or disease phase specific medicament |
| 04/14/2005 | CA2545639A1 Regulation of matrix metalloproteinases by psp94 family members |
| 04/14/2005 | CA2541974A1 Capsules of multilayered neutral polymer films associated by hydrogen bonding |
| 04/14/2005 | CA2541823A1 Hypoxia responsive human cngh 0002 genes and polypeptides |
| 04/14/2005 | CA2541240A1 Method for the production of a cell and/or tissue and/or disease phase specific medicament |
| 04/14/2005 | CA2540771A1 Nanoparticulate therapeutic biologically active agents |
| 04/14/2005 | CA2540699A1 Polysaccharides for pulmonary delivery of active agents |
| 04/14/2005 | CA2540666A1 Glucocerebroside treatment of disease |
| 04/14/2005 | CA2540253A1 Hiv-dependent expression constructs and uses therefor |
| 04/14/2005 | CA2537793A1 Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| 04/13/2005 | EP1522588A2 Accessory functions for use in recombinant AAV virion production |
| 04/13/2005 | EP1522583A2 RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (sina) |
| 04/13/2005 | EP1521963A2 Method and system for optimizing multi-epitope nucleic acid constructs and peptides encoded thereby |
| 04/13/2005 | EP1521847A2 Marker genes for determining renal toxicity |
| 04/13/2005 | EP1521839A1 Methods of making viral particles having a modified cell binding activity and uses thereof |
| 04/13/2005 | EP1521832A2 Genes |
| 04/13/2005 | EP1521768A2 RNA INTERFERENCE MEDIATED INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 04/13/2005 | EP1521766A2 SPLICEOSOME MEDIATED RNA i TRANS /i -SPLICING AND CORRECTION OF FACTOR VIII GENETIC DEFECTS USING SPLICEOSOME MEDIATED RNA TRANS SPLING |
| 04/13/2005 | EP1521594A2 Endogenous retrovirus polypeptides linked to oncogenic transformation |
| 04/13/2005 | EP1521523A2 Methods and compositions for delivering enzymes and nucleic acid molecules to brain, bone, and other tissues |
| 04/13/2005 | EP1465912A4 Novel chimeric tnf ligands |
| 04/13/2005 | EP1183353B1 Modified chimeric polypeptides with improved pharmacokinetic properties |
| 04/13/2005 | EP1015469B1 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleoide analogues |
| 04/13/2005 | EP0956052B1 Chimeric retrovirus/adenovirus system |
| 04/13/2005 | CN1606624A Vaccines |
| 04/13/2005 | CN1606565A Nucleic acids encoding recominant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 04/13/2005 | CN1606456A Restricted expression lentiviral vectors |
| 04/13/2005 | CN1605628A Human source anti-hepatitis A virus gene engineering antibody from CHO cell |
| 04/13/2005 | CN1605589A PC-1 gene promoter and its application |
| 04/13/2005 | CN1196797C Diagnostics and therapeutics for glaucoma |
| 04/13/2005 | CN1196787C Virulence genes and proteins and their use |
| 04/13/2005 | CN1196786C Methods for preventing graft rejection in transplantation and for producing universal gene therapy host cell |
| 04/13/2005 | CN1196784C Promoter of human endoglin gene and its use |
| 04/13/2005 | CN1196495C Mutant human CD80 and compositions and methods of making and using the same |
| 04/13/2005 | CN1196474C Liposome-entrapped DNA oral vaccines |
| 04/12/2005 | US6878817 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 04/12/2005 | US6878810 Zace1: a human metalloenzyme |
| 04/12/2005 | US6878806 Human secreted protein HTEEB42 |
| 04/12/2005 | US6878692 Nucleotide sequences coding apoptosis protein for use in the treatment of autoimmune diseases and cancer |
| 04/12/2005 | US6878549 Generating expression vector for use as gene transfer tool |
| 04/12/2005 | US6878547 Antisense oligonucleotides against tenascin for treating vitiligo |
| 04/12/2005 | US6878541 Papilloma pseudo-virus and preparation |
| 04/12/2005 | US6878371 Isolating autologous bone marrow- mononuclear cells from the subject; and transplanting locally into the tissue an effective amount of the autologous bone-marrow mononuclear cells, resulting in formation of new blood vessels in tissue |
| 04/07/2005 | WO2005030969A1 Method for mass production of human follicle stimulating hormone |
| 04/07/2005 | WO2005030939A2 Method and composition for regulating expansion of stem cells |
| 04/07/2005 | WO2005030799A1 Antisense compound and method for selectively killing activated t cells |
| 04/07/2005 | WO2005030787A2 Oligonucleotide compositions and methods for treating disease including inflammatory conditions |
| 04/07/2005 | WO2005030292A2 Methods, compositions and apparatus for delivering heterologous molecules to cells |
| 04/07/2005 | WO2005030261A1 Oncolytic adenoviral vectors encoding gm-csf |
| 04/07/2005 | WO2005030260A1 Bispecific oligonucleotide for the treatment of cns malignancies |
| 04/07/2005 | WO2005030259A2 Nucleic acid-lipophilic conjugates |
| 04/07/2005 | WO2005030253A2 Photocleavable dna transfer agent |
| 04/07/2005 | WO2005030122A2 Inactivated host cell delivery of polynucleotides encoding immunogens |
| 04/07/2005 | WO2005018657A3 NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY |
| 04/07/2005 | WO2005016960A3 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 04/07/2005 | WO2004108760A3 Improved secretion of neublastin |
| 04/07/2005 | WO2004105791A3 Recombinant anti-lhrh vaccines |
| 04/07/2005 | WO2004083380A3 Methods and compositions for modulating glycogen synthesis and breakdown |
| 04/07/2005 | WO2004052301A3 Modulation of matrix metalloproteinase 11 expression |
| 04/07/2005 | WO2004043978A3 2'-methoxy substituted oligomeric compounds and compositions for use in gene modulations |
| 04/07/2005 | WO2004041197A3 Methods of inhibiting glial scar formation |
| 04/07/2005 | WO2004013309A3 PAPSSs AS MODIFIERS OF THE AXIN PATHWAY AND METHODS OF USE |
| 04/07/2005 | WO2004010959A3 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
| 04/07/2005 | WO2004001072A3 Method for diagnosis of colorectal tumors |
| 04/07/2005 | WO2003090689A3 Neurodegenerative disorder treatment using gdnf secreting neural cells |
| 04/07/2005 | WO2003030612A3 Methods for modulating activity of the fxr nuclear receptor |
| 04/07/2005 | US20050076396 Adipocyte progenitor cell for use as tool in bone marrow harvesting; tissue engineering and regenerative medicine |
| 04/07/2005 | US20050075306 Inhibition of Syk kinase expression |
| 04/07/2005 | US20050075298 Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa |
| 04/07/2005 | US20050075268 cell is contacted with a photosentistising agent, cell is irradiated with light to activate photosentisitising agent, the cell is contacted with the molecule to be introduced, particularly for use in cancer treatment, gene therapy and vaccination |
| 04/07/2005 | US20050074886 Recombinant vector derived from adeno-associated virus for gene therapy |
| 04/07/2005 | US20050074885 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 04/07/2005 | US20050074881 Chronic pathogen-expressing cell lines |
| 04/07/2005 | US20050074879 Antisense oligonucleotide modulation of STAT3 expression |
| 04/07/2005 | US20050074849 Peptides |
| 04/07/2005 | US20050074819 Using ligand gated channel protein to identify modulators for prevention and treatment of tactile allodynia induced after nerve injury |
| 04/07/2005 | US20050074797 FHIT proteins and nucleic acids and methods based thereon |
| 04/07/2005 | US20050074771 For attachment to steroids, reporter molecules, reporter enzymes, lipophilic molecules, peptides or proteins; for detecting RNA in samples |
| 04/07/2005 | US20050074767 Using transcriptional activity of obesity genes as diagnostic indicator of efficacy of dietetic modulators; treating eating/weight disorders |
| 04/07/2005 | US20050074764 Using presence of point mutations in nicotinic acetylcholine receptor (nACHR) gene as diagnostic/prognosic tool in detction and treatment of indicator of cardiovascular, nervous system, vision and pain disorders |
| 04/07/2005 | US20050074762 Nucleotide sequences coding hormone protein for use in prevention and treatment of arteriosclerosis, diabetes, obesity and liver disorders |
| 04/07/2005 | US20050074761 Novel means for the diagnosis and therapy of ctcl |
| 04/07/2005 | US20050074755 Nucleotide sequences coding mutator locus gene for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 04/07/2005 | US20050074752 Expression vector comprising nucleotide sequences coding viral regulatory protein for use in transformation of muscle cell and generating vaccine for prevention of viral infection |
| 04/07/2005 | US20050074749 Method for the identification of extracellular domains of the epstein barr virus (ebv), tumor-associated latent membrane proteins and for the selection of antibody reagents reactive therewith |
| 04/07/2005 | US20050074747 Identifying peptide sequences that selectively bind to preferential bio-targets for use in diagnosis of viral disease, diabetes, inflammatory, arthritic, atherosclerotic, cell proliferative, autoimmune and cardiovascular disorders |
| 04/07/2005 | US20050074496 Utilizing such as fucoidan to treat surgical adhesions, arthritis, psoriasis; nontoxic, reduced side effects |
| 04/07/2005 | US20050074463 Therapeutic vaccination method, mutated peptides of hiv reverse transciptase and their use for vaccination and diagnostic purposes |
| 04/07/2005 | US20050074438 Peptidyl prolyl cis trans isomerase activity; antioxidants; preventing transplant rejection; myoblast cell line |
| 04/07/2005 | US20050074432 Trichoplusia ni, silkworms, Plutella xylostella in third instar; Autographa californica nucleopolyhedrovirus and Bombyx mori nucleopolyhedrovirus |
| 04/07/2005 | US20050074430 recombinant virus genetically engineered to have hypoxia induced factor replicates selectively in hypoxic cells or tissues |
| 04/07/2005 | US20050074427 IL-17 like molecules and uses thereof |
| 04/07/2005 | US20050074426 A conjugate of a cytokine and a tumor targeting moiety with numerous provisos |
| 04/07/2005 | CA2539972A1 Antisense compound and method for selectively killing activated t cells |
| 04/07/2005 | CA2539947A1 Igf-1 instructs multipotent adult cns neural stem cells to an oligodendroglial lineage |
| 04/07/2005 | CA2539837A1 Identification of tumour-associated cell surface antigens for diagnosis and therapy |
| 04/07/2005 | CA2539752A1 Oligonucleotide compositions and methods for treating disease including inflammatory conditions |
| 04/07/2005 | CA2539727A1 Bispecific oligonucleotide for the treatment of cns malignancies |
| 04/07/2005 | CA2538215A1 Staple oligonucleotides and medicaments comprising the same |
| 04/07/2005 | CA2536139A1 Nucleic acid-lipophilic conjugates |